- Home
- SIMO vs MYGN Comparison
SIMO vs MYGN Comparison
Compare SIMO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- MYGN
- Stock Information
- Founded
- SIMO 1995
- MYGN 1991
- Country
- SIMO Hong Kong
- MYGN United States
- Employees
- SIMO N/A
- MYGN N/A
- Industry
- SIMO Semiconductors
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SIMO Technology
- MYGN Health Care
- Exchange
- SIMO Nasdaq
- MYGN Nasdaq
- Market Cap
- SIMO 2.7B
- MYGN 642.0M
- IPO Year
- SIMO 2005
- MYGN 1995
- Fundamental
- Price
- SIMO $90.03
- MYGN $7.31
- Analyst Decision
- SIMO Strong Buy
- MYGN Hold
- Analyst Count
- SIMO 8
- MYGN 13
- Target Price
- SIMO $84.38
- MYGN $13.50
- AVG Volume (30 Days)
- SIMO 257.9K
- MYGN 1.4M
- Earning Date
- SIMO 10-29-2025
- MYGN 11-06-2025
- Dividend Yield
- SIMO 2.24%
- MYGN N/A
- EPS Growth
- SIMO N/A
- MYGN N/A
- EPS
- SIMO 2.30
- MYGN N/A
- Revenue
- SIMO $768,738,000.00
- MYGN $832,900,000.00
- Revenue This Year
- SIMO $5.44
- MYGN $0.17
- Revenue Next Year
- SIMO $15.56
- MYGN $6.19
- P/E Ratio
- SIMO $38.57
- MYGN N/A
- Revenue Growth
- SIMO N/A
- MYGN 3.83
- 52 Week Low
- SIMO $37.21
- MYGN $3.76
- 52 Week High
- SIMO $90.55
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- SIMO 73.43
- MYGN 66.23
- Support Level
- SIMO $77.22
- MYGN $6.73
- Resistance Level
- SIMO $90.50
- MYGN $7.80
- Average True Range (ATR)
- SIMO 2.93
- MYGN 0.41
- MACD
- SIMO 0.93
- MYGN 0.06
- Stochastic Oscillator
- SIMO 96.10
- MYGN 75.74
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.